华熙生物2025年净利润同比增长67.03%

Core Viewpoint - Huaxi Bio reported a significant decline in total operating revenue for 2025, while net profit showed substantial growth, indicating a shift in business strategy and cost management [1] Financial Performance - The company achieved total operating revenue of 4.217 billion yuan in 2025, a decrease of 21.49% compared to the previous year [1] - The net profit attributable to shareholders of the parent company was 291 million yuan, an increase of 67.03% year-on-year [1] - The net profit attributable to shareholders of the parent company, excluding non-recurring gains and losses, was 188 million yuan, reflecting a 75.28% increase from the previous year [1] Business Strategy - The changes in performance are primarily attributed to the company's ongoing optimization of business structure and resource allocation [1] - A reduction in sales and management expenses contributed to the improved profitability despite the decline in revenue [1]